| MISERY, Laurent |
MADULO, NCT05642208: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis |
|
|
| Recruiting | 4 | 256 | Europe, RoW | Dupilumab step-down | Nantes University Hospital | Atopic Dermatitis, Eczema, Atopic | 03/26 | 03/26 | | |
RITUX-MMP, NCT03295383: Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid |
|
|
| Recruiting | 3 | 130 | Europe | Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of Rituximab, Placebo Oral Tablet | University Hospital, Rouen | Severe Forms of Mucous Membrane Pemphigoid | 11/22 | 11/23 | | |
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary |
|
|
| Recruiting | N/A | 6000 | Europe | Biological, Tissular, Quality of life | Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI) | Malignant Melanoma | 03/24 | 03/24 | | |
| Recruiting | N/A | 9000 | Europe | | University Hospital, Lille | Adnexal Tumor of Skin, Merkel Cell Carcinoma, Advanced Basal Cell Carcinoma Requiring Systemic Treatment | 12/25 | 12/25 | | |
COVER, NCT04352036: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the Cohort (Verneuil Cohort) |
|
|
| Recruiting | N/A | 465 | Europe | no interventional study | Nantes University Hospital | Acute Hidrosadenitis | 02/30 | 02/30 | | |
| Not yet recruiting | N/A | 100 | Europe | | Nantes University Hospital, LEO Pharma | Atopic Dermatitis | 07/25 | 03/26 | | |
| SENESCHAL, Julien |
MADULO, NCT05642208: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis |
|
|
| Recruiting | 4 | 256 | Europe, RoW | Dupilumab step-down | Nantes University Hospital | Atopic Dermatitis, Eczema, Atopic | 03/26 | 03/26 | | |
NCT06239311: Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis. |
|
|
| Recruiting | 3 | 212 | Europe, RoW | Methotrexate, Placebo | medac GmbH | Moderate to Severe Atopic Dermatitis | 11/25 | 03/26 | | |
| Recruiting | 3 | 128 | Europe | Deucravacitinib, Volunteer without treatment | Centre Hospitalier Universitaire de Nice | Vitiligo, Generalized | 05/26 | 11/26 | | |
PSSIT, NCT05098704: Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk |
|
|
| Recruiting | 2/3 | 90 | Europe | clopidogrel treatment, Placebo | University Hospital, Bordeaux, Ministry for Health and Solidarity, France | Scleroderma, Systemic Sclerosis | 06/30 | 06/30 | | |
BARVIT, NCT04822584: Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo |
|
|
| Completed | 2 | 49 | Europe | Baricitinib Oral Product, Placebo | University Hospital, Bordeaux | Vitiligo | 04/23 | 04/23 | | |
| Recruiting | 2 | 94 | Europe | Dupilumab, placebo | University Hospital, Toulouse | Chronic Hand Eczema | 01/24 | 06/24 | | |
METVI, NCT04237103: Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults with Progressive Vitiligo |
|
|
| Recruiting | 2 | 45 | Europe | Methotrexate, narrow-band UVB phototherapy, Placebos | University Hospital, Bordeaux | Vitiligo | 10/25 | 10/25 | | |
VITANI, NCT05917561: Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo |
|
|
| Recruiting | 2 | 48 | Europe | Anifrolumab Infusion Product, Placebo | University Hospital, Bordeaux, AstraZeneca | Vitiligo | 05/26 | 05/26 | | |
| Not yet recruiting | N/A | 175 | Europe | skin swabs at lesional and non-lesional sites, skin swabs on skin | University Hospital, Bordeaux, Centre National de la Recherche Scientifique, France | Vitiligo, Skin Melanoma | 05/23 | 05/23 | | |
INFLAMMAVit, NCT03976622: Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata |
|
|
| Not yet recruiting | N/A | 450 | Europe | Blood samples, Blood samples: serum and PBMC, Skin biopsies | University Hospital, Bordeaux | Vitiligo, Psoriasis, Alopecia Areata, Atopic Dermatitis | 06/23 | 06/23 | | |
| Completed | N/A | 50 | Europe | blood sample | University Hospital, Bordeaux | Systemic Lupus Erythematosus | 02/22 | 02/22 | | |
| Recruiting | N/A | 80 | Europe | Skin biopsies and blood samples | Poitiers University Hospital | Atopic Dermatitis, Staphylococcus Aureus, Bacterial Toxins, Immune Response, Cytokines, T Cells Subsets | 10/23 | 10/23 | | |
VASC-FAS, NCT03698071: Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis |
|
|
| Recruiting | N/A | 50 | Europe | blood sample, urine sample | University Hospital, Bordeaux, National Research Agency, France | ANCA Associated Vasculitis | 12/24 | 12/24 | | |
PB-DEPIST, NCT06148090: Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) |
|
|
| Recruiting | N/A | 50 | Europe | clobetasol decreasing measurement | University Hospital, Bordeaux | Pemphigoid, Bullous, Adrenal Insufficiency | 01/26 | 01/26 | | |
NCT06446063: Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients. |
|
|
| Recruiting | N/A | 50 | Europe | Test product, Control Product | Pierre Fabre Dermo Cosmetique | Vitiligo | 06/25 | 06/25 | | |
STRAVI, NCT05927272: Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions |
|
|
| Recruiting | N/A | 10 | Europe | SKIN SAMPLES, BLOOD SAMPLES, narrowband UVB, Systemic Steroids | University Hospital, Bordeaux, Centre National de la Recherche Scientifique, France | Vitiligo | 10/25 | 10/25 | | |
ISLE, NCT04276701: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases |
|
|
| Recruiting | N/A | 500 | Europe | blood sample, Ultrasonography assessment, questionnaires | University Hospital, Bordeaux, Foundation for Research in Rheumatology (FOREUM) | Systemic Lupus Erythematosus | 03/27 | 03/27 | | |
SCLERESO, NCT04265144: Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre |
|
|
| Recruiting | N/A | 500 | Europe | Blood samples, Biopsy, Bronchoalveolar samples | University Hospital, Bordeaux | Scleroderma, Systemic Sclerosis | 06/30 | 06/30 | | |
| Not yet recruiting | N/A | 100 | Europe | | Nantes University Hospital, LEO Pharma | Atopic Dermatitis | 07/25 | 03/26 | | |
| MAHE, Emmanuel |
MADULO, NCT05642208: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis |
|
|
| Recruiting | 4 | 256 | Europe, RoW | Dupilumab step-down | Nantes University Hospital | Atopic Dermatitis, Eczema, Atopic | 03/26 | 03/26 | | |
RITUX-MMP, NCT03295383: Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid |
|
|
| Recruiting | 3 | 130 | Europe | Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of Rituximab, Placebo Oral Tablet | University Hospital, Rouen | Severe Forms of Mucous Membrane Pemphigoid | 11/22 | 11/23 | | |
ETHNIC, NCT06447480: Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients |
|
|
| Not yet recruiting | 3 | 420 | Europe | ISOtretinoin 5 MG, Topical cream | Centre Hospitalier Universitaire de Nice | Acne Vulgaris | 09/26 | 09/27 | | |
| CONTOU, Damien |
SPLEEN, NCT04199403: Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients |
|
|
| Recruiting | N/A | 6000 | Europe | | Poitiers University Hospital, Pr Pierre BUFFET Institut National de la Transfusion Sanguine, Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier | Asplenia | 01/40 | 01/40 | | |
